Search

everythinglearnresearchcommunity

for

Search:↓

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

Forensic hair analysis for drugs is now more reliable and accurate.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Women with PCOS are much more likely to experience depression.

Using microneedling with platelet-rich plasma is more effective and just as safe as microneedling alone for treating acne scars.

Certain medications and conditions increase the risk of intraoperative floppy-iris syndrome.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

Combining PRP with minoxidil significantly improves hair growth in AGA patients.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Low-level laser therapy helps increase hair density in androgenetic alopecia.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.